18-MC Compound not checked
Definium Therapeutics US, Inc.
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Addiction
- Main trialPhase 1
- “The primary objective of this study is to assess the safety and tolerability of a single day dosing and a separate multiple day dosing of 18-MC HCl administered orally, each part of the study having a different set of healthy male and female volunteers.”In the company’s words, NCT04292197 on ClinicalTrials.gov
Other drugs for Addiction
- AFA-281Afasci Inc · Phase 2
- 1 Nalmefene implantReacX Pharmaceuticals, Inc. · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Completed | 13 Dec 2021 | A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026